As of Nov 24
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for GlycoMimetics Inc have a median target of 19.00, with a high estimate of 25.00 and a low estimate of 15.00. The median estimate represents a +49.96% increase from the last price of 12.67.
The current consensus among 5 polled investment analysts is to Buy stock in GlycoMimetics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.